Literature DB >> 10920951

[8-chloro-adenosine induced apoptosis in various human tumor cell lines].

S Zhang1, D Zheng, S Liu.   

Abstract

OBJECTIVE: To study the effect of 8-Chloro-adenosine (8CA) on tumor cell growth and apoptosis.
METHODS: Tumor and normal cell lines were treated with 8CA at different concentrations and cell growth was analysed by MTT assay. Cell apoptosis was evaluated by light microscopy, flow cytometry and chromosome DNA fragmentation.
RESULTS: Treatment with 8CA at 10 mumol/L remarkably inhibited tumor cell growth. HL-60 promyelocytic leukemia cell line was more sensitive to 8CA than MGc-803 gastric mucoid adenocarcinoma cell line. NIH3T3 cells were relatively resistant to 8CA. The IC50 of HL-60 and MGc-803 cells was 1.2 mumol/L and 1.8 mumol/L, respectively, while that of NIH3T3 cells was 12 mumol/L. Further study showed that 8CA induced HL-60 and MGc-803 cell death characterized by apoptotic phenotypes, DNA content changes and chromosome DNA fragmentation.
CONCLUSION: 8CA is a potential agent for tumor chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10920951

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  8-Cl-adenosine inhibits proliferation and causes apoptosis in B-lymphocytes via protein kinase A-dependent and independent effects: implications for treatment of Carney complex-associated tumors.

Authors:  Audrey J Robinson-White; Ioannis Bossis; Hui-Pin Hsiao; Maria Nesterova; Wolfgang W Leitner; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-09-22       Impact factor: 5.958

2.  Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine.

Authors:  Audrey J Robinson-White; Hui-Pin Hsiao; Wolfgang W Leitner; Elizabeth Greene; Andrew Bauer; Nancy L Krett; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2007-12-11       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.